Outset Medical (OM) Cash from Investing Activities (2019 - 2026)
Outset Medical has reported Cash from Investing Activities over the past 7 years, most recently at $8.6 million for Q4 2025.
- Quarterly Cash from Investing Activities fell 92.06% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$97.7 million through Dec 2025, down 193.98% year-over-year, with the annual reading at -$97.7 million for FY2025, 193.98% down from the prior year.
- Cash from Investing Activities was $8.6 million for Q4 2025 at Outset Medical, up from $3.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $108.2 million in Q4 2024 and troughed at -$97.5 million in Q2 2021.
- The 5-year median for Cash from Investing Activities is $663500.0 (2022), against an average of -$6.0 million.
- Year-over-year, Cash from Investing Activities surged 2163.3% in 2023 and then plummeted 2333.48% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$16.4 million in 2021, then plummeted by 215.19% to -$51.7 million in 2022, then surged by 145.27% to $23.4 million in 2023, then soared by 361.7% to $108.2 million in 2024, then crashed by 92.06% to $8.6 million in 2025.
- Per Business Quant, the three most recent readings for OM's Cash from Investing Activities are $8.6 million (Q4 2025), $3.0 million (Q3 2025), and -$31.2 million (Q2 2025).